SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome
LIPO 0.215+22.9%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dalroi who wrote (766)8/24/1999 9:24:00 PM
From: KM  Read Replies (2) of 900
 
Okay, someone educate me. I just read the transcript of the earnings conference call in July and quote the following passage:

*************************************************

"As far as the timing is concerned, we have just learned that EVACET will go before the Oncology Drug Advisory Committee here in the U.S. on the afternoon of September 16th. We expect to get an answer from the FDA sometime after that meeting, but before the end of the year."

***********************************************

Now, if I read this correctly, it sounds like they go in and make a presentation, answer questions, or whatever, and then, the FDA goes away for awhile and issues a recommendation at some later date (not the same day).

Is this correct? If so, why is everyone keying on that September 16 date if there will be no response that day? This is rhetorical question. I have no prior experience in this FDA procedure so I'd appreciate any insights. Thanks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News